Custom supplement formulation

Formulate a custom supplement around real demand, and own the formula, not a catalog SKU.

Most founders lock in a stock formula or a manufacturer first, then find the economics don't work. Define the customer, the cost, the margin, and the claims boundaries before the formula narrows your options.

Ph.D.-led strategyProduct brief before supplier commitmentBusiness case, sample, and market connected
Ph.D. in Molecular Medicine Harvard Medical School postdoctoral research MBA in Healthcare Transformation Science + R&D + manufacturing + commercialization

A formula can be technically valid and still fail as a business.

A manufacturer will happily quote you. That proves the formula can be made. It says nothing about whether the product meets the customer need, the price, the margin, and the claims pathway at the same time.

A manufacturer will happily quote you. That proves the formula can be made, not that it meets the customer need, the price, the margin, and the claims pathway at once.

Most supplement projects begin with an ingredient list or a catalog. That reverses the order. The customer, the use case, the economics, and the evidence you will need should shape the brief before the formulation is fixed.

Launch Lab builds the decision framework your formulator, testing partner, manufacturer, and commercial team all work against, so the product that gets made is the one the business actually needs.

Start with the demand.

Name the repeated customer need, the buyer, and the gap in the category. If the product has no reason to exist, better to learn that now.

Build a target product profile.

Set the format, the experience, the cost target, and the claims you can stand behind before you review a single sample.

Make samples answer a question.

Judge taste, texture, format, and cost against written criteria, not against whichever sample happens to land on your desk first.

Model the economics early.

Connect target cost, price, channel, and contribution margin while changing direction is still cheap.

Custom formulation is not the same as choosing a formula from a catalog.

Catalog-first route

The available formula drives the decision.

The supplier starts from what it already makes. Your positioning, your economics, and your customer story then bend to fit that formula.

  • Formula and format are mostly predetermined
  • Differentiation often rests on label and packaging
  • Economics are accepted after the quote
  • A similar product may be available to competitors

Launch Lab route

The business case drives the product brief.

The customer, the economics, the experience, and the claims pathway drive every formulation and sample decision, in that order.

  • Demand and target economics defined first
  • Sample criteria tied to the product brief
  • Partner requirements written before selection
  • Go-to-market developed with the product

One business case across every handoff.

Demand, product, sample, and market decisions are developed together so a late-stage choice does not undo the work that came before it.

Validate the opportunity

Define the customer, repeated need, channel advantage, target economics, and strategic reason the product should exist.

Define the product

Translate the business case into a target product profile with format, experience, performance intent, differentiation, and constraints.

Prove the sample

Evaluate samples against the brief, not against what happens to be easiest for a supplier to provide.

Prepare the market

Connect the selected direction to pricing, positioning, partners, launch sequencing, proof, and decision gates.

The working set needed to move from concept to a disciplined development decision.

Each engagement is scoped to the opportunity. The deliverables create a shared brief across product, formulation, sampling, manufacturing, and commercialization.

Product Opportunity Brief

Customer, problem, use context, strategic role, opportunity boundaries, and decision gates.

Target Product Profile

Format, experience, performance intent, differentiation, cost targets, and sample criteria.

Formulation & Sample Plan

A route for formulation direction, sample creation, comparison, feedback, revision, and stop/go decisions.

Pricing & Margin Model

Target cost, channel, price, volume, and contribution-margin assumptions.

Manufacturing Partner Criteria

Requirements, partner-selection questions, minimums, tradeoffs, documentation, and scale-readiness considerations.

Claims & Evidence Questions

Early claims boundaries, evidence needs, and questions for qualified regulatory and legal review.

Commercialization Blueprint

Positioning, offer, launch sequence, channels, proof plan, and milestones.

Relevant proof should show the work between the idea and the result.

The record behind the process

17×

The scientist-led process founders work through here was built on real operating experience, including scaling cGMP production 17× and cutting manufacturing cost by 45%.
Dr. Maryam Alavi / Founder, BiotechNmed Launch Lab

Why it matters to you

A scientist who has actually built and scaled products.

The same rigor that scaled cGMP production and cut manufacturing cost is applied directly to your formula, your documentation, and your path to market. You work with Dr. Alavi, not a handoff to a junior team.

A scientist-operator who understands the handoffs that make products expensive.

Dr. Maryam Alavi has worked across research, regenerative medicine, R&D, manufacturing, sales, business development, and commercialization. That breadth helps keep the product brief, sample decisions, economics, and market plan connected.

Dr. Maryam Alavi, founder and CEO of BiotechNmed

Why the operating range matters

Technical choices become business choices quickly.

A product can be perfectly feasible and still miss its cost target, its positioning, or its channel. Launch Lab is built to surface those conflicts before they harden into expensive commitments.

Scientific rigorResearch and product-development experience that informs feasibility and evidence questions.
Commercial judgmentExperience across sales, business development, partnerships, and go-to-market decisions.
Operating contextManufacturing and R&D experience inside the handoffs where cost and execution risk accumulate.
Founder perspectiveA woman-owned business built from the ground up, without treating commercialization as an afterthought.

A strong fit starts with an advantage you already have.

Strong fit

  • You already have customers, patients, an audience, distribution, or category authority.
  • You can name a repeated need, margin opportunity, or product gap.
  • You want a differentiated product rather than a catalog SKU with new packaging.
  • You can commit management attention and realistic development capital.

Not the right fit

  • You require guaranteed revenue, medical outcomes, approval, patentability, or valuation.
  • Your only goal is the fastest or cheapest generic product.
  • You do not yet have a clear customer, channel, or operating capacity.
  • You are unwilling to validate assumptions or revise the concept.

What decision-makers usually need to know.

Yes. The work may focus on product positioning, target product profile, sample criteria, economics, claims questions, partner requirements, or commercialization. An existing formula is an input, not proof that the product case is complete.
No blanket in-house claim should be assumed. BiotechNmed leads product and commercialization strategy and may coordinate with qualified formulation, testing, regulatory, legal, manufacturing, packaging, and other partners as the scope requires.
No. Launch Lab is a product-development and commercialization incubator. Manufacturing, specialized testing, regulatory work, legal work, and other regulated services may be performed by qualified external partners and should be defined transparently in the final scope.
You may enter with a repeated customer need, a product concept, an existing formula or prototype, a supplier proposal, or an in-market product that needs stronger economics, positioning, or commercialization logic.
Ownership of formulas, specifications, samples, documentation, third-party work product, and potential intellectual property must be defined in the final scope and contract. Patentability, freedom to operate, and legal ownership require qualified counsel.
No. The process is intended to improve decision quality, expose risk, and create a coherent product and commercialization plan. Regulatory status, claims, legal matters, financial performance, and commercial outcomes are not guaranteed.
Scope depends on product category, development stage, sampling requirements, third-party work, and commercialization complexity. A proposal is provided after the opportunity, constraints, and required work are understood.

Product Opportunity Assessment

Validate the opportunity before you fund the product.

Tell us what your customers need, what advantage the business already has, and what you want the product to accomplish. The first decision is whether the opportunity deserves deeper work.

The assessment is a fit and decision review, not a promise of formulation, regulatory status, patentability, medical outcomes, or commercial success.

Do not include patient names, medical records, or sensitive health information. By submitting, you consent to being contacted about this request. Review the Privacy Policy.